Additionally, significant changes in metabolic pathways in both CLDN1-knockdowned or PDS-0330-treated GIST cells (Figure 11A,B) are in concordance with recent findings [42]. This evidence concerns the gene CLDN1 and gastrointestinal stromal tumor.